156
Views
7
CrossRef citations to date
0
Altmetric
Meeting Report

Ethical, legal and social implications of rare diseases and orphan drugs in Europe: meeting report of a Brocher symposium

, , &
Pages 571-573 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jaroslav Kacetl, Petra Marešová, Raihan Maskuriy & Ali Selamat. (2020) Ethical Questions Linked to Rare Diseases and Orphan Drugs – A Systematic Review. Risk Management and Healthcare Policy 13, pages 2125-2148.
Read now

Articles from other publishers (6)

Alessandra Blonda, Yvonne Denier, Isabelle Huys, Pawel Kawalec & Steven Simoens. (2022) How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries. Frontiers in Pharmacology 13.
Crossref
Conor M.W. Douglas, Dimitra Panagiotoglou, Nick Dragojlovic & Larry Lynd. (2021) Methodology for constructing scenarios for health policy research: The case of coverage decision-making for drugs for rare diseases in Canada. Technological Forecasting and Social Change 171, pages 120960.
Crossref
Bettina M. Zimmermann, Johanna Eichinger & Matthias R. Baumgartner. (2021) A systematic review of moral reasons on orphan drug reimbursement. Orphanet Journal of Rare Diseases 16:1.
Crossref
Alessandra Blonda, Yvonne Denier, Isabelle Huys & Steven Simoens. (2021) How to Value Orphan Drugs? A Review of European Value Assessment Frameworks. Frontiers in Pharmacology 12.
Crossref
Kylie Tingley, Doug Coyle, Ian D. Graham, Lindsey Sikora, Pranesh Chakraborty, Kumanan Wilson, John J. Mitchell, Sylvia Stockler-Ipsiroglu & Beth K. Potter. (2018) Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases. Orphanet Journal of Rare Diseases 13:1.
Crossref
J. Torrent-Farnell, M. Comellas, J.L. Poveda, I. Abaitua, L.G. Gutiérrez-Solana, J. Pérez-López, J. Cruz, J. Urcelay & L. Lizán. (2018) The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus. Health Policy 122:6, pages 590-598.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.